A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19047126

Clin. Cancer Res. 2008 Dec 1 14 23 7940-6

Download in:

View as

Triples

General Info

PMID
19047126